BioLargo, Inc. (BLGO)

Market Cap	54.06M -26.8%
Revenue (ttm)	7.77M -56.3%
Net Income	-11.78M
EPS	-0.04
Shares Out	319.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,891
Average Volume	191,245
Open	0.1617
Previous Close	0.1700
Day's Range	0.1611 - 0.1694
52-Week Range	0.1401 - 0.3000
Beta	-0.17
RSI	45.53
Earnings Date	Mar 30, 2026

About BioLargo

BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company’s technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platf...

• Industry: Chemicals
• Sector: Materials
• Founded: 1991
• Employees: 42
• Stock Exchange: OTCMKTS
• Ticker Symbol: BLGO

Financial Performance

In 2025, BioLargo's revenue was $7.77 million, a decrease of -56.32% compared to the previous year's $17.78 million. Losses were -$11.78 million, 390.4% more than in 2024.